Surgery Partners Q2 FY26 net loss widens to $15 million; revenue rises 2.7% to $848.9 million

Reuters2026/08/10 11:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Surgery Partners posted Q2 2026 revenue up 2.7% to $848.9 million; net loss attributable to shareholders widened to $15 million.
Adjusted EBITDA (non-GAAP) slipped to $125.2 million; adjusted EBITDA margin fell 0.9 percentage points to 14.7%.
Same-facility revenue rose 5% on 4.8% higher revenue per case; same-facility cases increased 0.3%.
Management highlighted a pending Idaho Falls divestiture to Intermountain Health as part of portfolio optimization and deleveraging.
Full-year 2026 guidance was reaffirmed at $3.35 billion-$3.45 billion revenue, adjusted EBITDA (non-GAAP) of at least $530 million, excluding the pending divestiture.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Surgery Partners Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608100730PRIMZONEFULLFEED9806512) on August 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Surgery Partners Q2 FY26 net loss widens to $15 million; revenue rises 2.7% to $848.9 million

You may also like

Crypto prices